Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Correction (v54,p539)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cossette, P.
Right arrow Articles by Carmant, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cossette, P.
Right arrow Articles by Carmant, L.
Neurology 1999;52:1691
© 1999 American Academy of Neurology


Brief Communications

ACTH versus vigabatrin therapy in infantile spasms: A retrospective study

Patrick Cossette, MD, MSc, James J. Riviello, MD and Lionel Carmant, MD

From the Department of Pediatrics (Neurology) (Drs. Cossette and Carmant), Université de Montréal, Hôpital Sainte-Justine, Montréal, Québec, Canada; and Department of Neurology (Dr. Riviello), Harvard Medical School, Children’s Hospital, Boston, MA.

Address correspondence and reprint requests to Dr. Lionel Carmant, Service de Neurologie, Hôpital Sainte-Justine, 3175, Côte Sainte-Catherine, Montréal, Qc, H3T 1C5 Canada; e-mail: carmantl{at}ere.umontreal.ca

ACTH is the standard treatment for infantile spasms (IS) in North America. Recent reports showed that vigabatrin is a valuable treatment for IS, but comparative studies with ACTH are limited. In this study, we compare the effectiveness of ACTH versus vigabatrin on IS. Our results support that vigabatrin is as effective as and better tolerated than ACTH. Because of their similar efficacy, we believe that vigabatrin should be the first intention drug for the treatment of IS.




This article has been cited by other articles:


Home page
J Child NeurolHome page
M. Milh, N. Villeneuve, F. Chapon, S. Pineau, S. Lamoureux, M.-O. Livet, C. Bartoli, C. Hugonenq, J. Mancini, B. Chabrol, et al.
Transient Brain Magnetic Resonance Imaging Hyperintensity in Basal Ganglia and Brain Stem of Epileptic Infants Treated With Vigabatrin
J Child Neurol, March 1, 2009; 24(3): 305 - 315.
[Abstract] [PDF]


Home page
NeurologyHome page
M. T. Mackay, S. K. Weiss, T. Adams-Webber, S. Ashwal, D. Stephens, K. Ballaban-Gill, T. Z. Baram, M. Duchowny, D. Hirtz, J. M. Pellock, et al.
Practice Parameter: Medical Treatment of Infantile Spasms: Report of the American Academy of Neurology and the Child Neurology Society
Neurology, May 25, 2004; 62(10): 1668 - 1681.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
A Nicolson, J P Leach, D W Chadwick, and D F Smith
The legacy of vigabatrin in a regional epilepsy clinic
J. Neurol. Neurosurg. Psychiatry, September 1, 2002; 73(3): 327 - 329.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
Y. Suzuki, K. Imai, Y. Toribe, H. Ueda, K. Yanagihara, K. Shimono, T. Okinaga, J. Ono, T. Nagai, T. Matsuoka, et al.
Long-term response to zonisamide in patients with West syndrome
Neurology, May 28, 2002; 58(10): 1556 - 1559.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
E. H. Kossoff, P. L. Pyzik, J. R. McGrogan, E. P. G. Vining, and J. M. Freeman
Efficacy of the Ketogenic Diet for Infantile Spasms
Pediatrics, May 1, 2002; 109(5): 780 - 783.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
L. Carmant
Infantile Spasms: West Syndrome
Arch Neurol, February 1, 2002; 59(2): 317 - 318.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
E. Trevathan
Infantile Spasms and Lennox-Gastaut Syndrome
J Child Neurol, February 1, 2002; 17(2_suppl): 2S9 - 2S22.
[Abstract] [PDF]


Home page
NeurologyHome page
R. Sankar and C. G. Wasterlain
Is the devil we know the lesser of two evils?
Neurology, May 1, 1999; 52(8): 1537 - 1537.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by AAN Enterprises, Inc.